Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
- PMID: 33675692
- PMCID: PMC9191863
- DOI: 10.1016/j.cell.2021.02.012
Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
Abstract
The prevalence of type 2 diabetes and obesity has risen dramatically for decades and is expected to rise further, secondary to the growing aging, sedentary population. The strain on global health care is projected to be colossal. This review explores the latest work and emerging ideas related to genetic and environmental factors influencing metabolism. Translational research and clinical applications, including the impact of the COVID-19 pandemic, are highlighted. Looking forward, strategies to personalize all aspects of prevention, management and care are necessary to improve health outcomes and reduce the impact of these metabolic diseases.
Keywords: circadian clock; diet; environment; exercise; genetics; inflammation; metabolism; personalized medicine; thermal regulation; treatment.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests. J.R.Z. is member of Cell Advisory Board.
Figures
References
-
- Achebak H., Devolder D., Ballester J. Trends in temperature-related age-specific and sex-specific mortality from cardiovascular diseases in Spain: a national time-series analysis. Lancet Planet. Health. 2019;3:e297–e306. - PubMed
-
- Ahlqvist E., Storm P., Käräjämäki A., Martinell M., Dorkhan M., Carlsson A., Vikman P., Prasad R.B., Aly D.M., Almgren P., et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–369. - PubMed
-
- Al-Mrabeh A., Zhyzhneuskaya S.V., Peters C., Barnes A.C., Melhem S., Jesuthasan A., Aribisala B., Hollingsworth K.G., Lietz G., Mathers J.C., et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metab. 2020;31:233–249 e234. - PubMed
-
- Ameln H., Gustafsson T., Sundberg C.J., Okamoto K., Jansson E., Poellinger L., Makino Y. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005;19:1009–1011. - PubMed
-
- American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
